Amneal Pharmaceuticals Inc banner
A

Amneal Pharmaceuticals Inc
F:2DT

Watchlist Manager
Amneal Pharmaceuticals Inc
F:2DT
Watchlist
Price: 12.3 EUR 3.36% Market Closed
Market Cap: €3.8B

Wall Street
Price Targets

2DT Price Targets Summary
Amneal Pharmaceuticals Inc

Wall Street analysts forecast 2DT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2DT is 11.67 EUR with a low forecast of 10.36 EUR and a high forecast of 12.43 EUR.

Lowest
Price Target
10.36 EUR
16% Downside
Average
Price Target
11.67 EUR
5% Downside
Highest
Price Target
12.43 EUR
1% Upside
Amneal Pharmaceuticals Inc Competitors:
Price Targets
OFN
Orell Fuessli AG
6% Upside

Revenue
Forecast

14% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
14% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Amneal Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 8%.

Operating Income
Forecast

9% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-45%
Average Miss
9% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-45%
Average Miss

For the last 13 years the compound annual growth rate for Amneal Pharmaceuticals Inc's operating income is 9%. The projected CAGR for the next 3 years is 31%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2DT's stock price target?
Price Target
11.67 EUR

According to Wall Street analysts, the average 1-year price target for 2DT is 11.67 EUR with a low forecast of 10.36 EUR and a high forecast of 12.43 EUR.

What is Amneal Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Amneal Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 8%.

What is Amneal Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
31%

For the last 13 years the compound annual growth rate for Amneal Pharmaceuticals Inc's operating income is 9%. The projected CAGR for the next 3 years is 31%.

Back to Top